The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase

British Journal of Pharmacology
T E WebbE A Barnard

Abstract

1. B10 cells, a clonal line of rat brain capillary endothelial cells, exhibit a single P2 purinoceptor, activation of which leads to increases in free intracellular calcium. In the current study the identity of this P2Y receptor was determined by its binding parameters for a range of purinoceptor ligands and by its complementary DNA (cDNA) sequence. The signal transduction mechanism activated by this receptor was also investigated. 2. The radioligand [35S]-dATP alpha S bound with high affinity (Kd = 9.8 nM) to the P2Y purinoceptor expressed on B10 cells, which was found to be extremely abundant (Bmax = 22.5 pmol mg-1 protein). The calculated Ki values of a range of P2 purinoceptor agonists which competitively displaced binding of [35S]-dATP alpha S led to the rank order of affinity: dATP alpha S (Ki 3.4 nM) > 2-chloroATP (2-ClATP) (13 nM), ATP (22 nM) > ATP gamma S (43 nM) > 2-methylthioATP (2-MeSATP) (88 nM) > ADP (368 nM) > > UTP, L-beta,gamma-methyleneATP (both > 10,000 nM). The P2 purinoceptor antagonists, Reactive blue 2 and suramin, were also able to displace binding, with Ki values of 833 and 1358 nM respectively. In contrast pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid 4-sodium (PPADS) was able to displace onl...Continue Reading

References

Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A RichardsonE A Barnard
Aug 26, 1991·Biochimica Et Biophysica Acta·B JuulL Plesner
Jan 1, 1990·Annals of the New York Academy of Sciences·G Burnstock
Nov 30, 1990·Biochimica Et Biophysica Acta·O CulićT Zanić-Grubisić
Feb 1, 1988·British Journal of Pharmacology·P M Dunn, A G Blakeley
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
May 1, 1995·Pharmacology & Toxicology·J SimonE A Barnard
May 1, 1995·Trends in Pharmacological Sciences·C Kennedy, P Leff
Jul 17, 1995·Biochemical and Biophysical Research Communications·D J HendersonI A Dainty
Jun 1, 1995·Trends in Pharmacological Sciences·T Kenakin
Jul 1, 1995·Trends in Pharmacological Sciences·T Kenakin
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K D LustigD Julius
Jan 1, 1995·Pflügers Archiv : European journal of physiology·A U ZiganshinG Burnstock
May 17, 1995·Biochemical Pharmacology·G F Wilkinson, M R Boarder
Jun 6, 1995·Biochemical and Biophysical Research Communications·Y TokuyamaG I Bell
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·C E ParrJ T Turner
Jan 1, 1995·American Journal of Respiratory Cell and Molecular Biology·W R RiceD T Fiedeldey
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·C E ParrJ T Turner
Mar 1, 1994·Trends in Pharmacological Sciences·E A BarnardT E Webb
Sep 1, 1993·The American Journal of Physiology·G R Dubyak, C el-Moatassim
Dec 1, 1993·British Journal of Pharmacology·A U ZiganshinG Burnstock
Jan 26, 1996·Biochemical and Biophysical Research Communications·K AyyanathanS P Kunapuli
Nov 1, 1995·British Journal of Pharmacology·C BrownM R Boarder
Feb 6, 1996·Biochemical and Biophysical Research Communications·T E WebbE A Barnard
Aug 2, 1996·The Journal of Biological Chemistry·G K AkbarS P Kunapuli
Nov 30, 1995·European Journal of Pharmacology·J SimonE A Barnard
May 1, 1996·British Journal of Pharmacology·J B SchachterT K Harden

❮ Previous
Next ❯

Citations

Apr 29, 1998·Molecular Neurobiology·G D Housley
Jul 16, 2013·Progress in Neurobiology·Marijke De BockLuc Leybaert
Nov 19, 1997·Neuropharmacology·J SimonE A Barnard
Jun 28, 2000·Journal of the Autonomic Nervous System·N J Cusack, S M Hourani
Aug 2, 2001·Trends in Pharmacological Sciences·E A Barnard, J Simon
May 19, 1998·Trends in Pharmacological Sciences·M R Boarder, S M Hourani
Jun 1, 1997·Current Opinion in Neurobiology·R A North, E A Barnard
Dec 24, 1997·British Journal of Pharmacology·J B SchachterT K Harden
Oct 8, 1999·British Journal of Pharmacology·Z AnwarM R Boarder
Mar 1, 2000·British Journal of Pharmacology·G LenzJ T Neary
Nov 13, 2001·British Journal of Pharmacology·H FrankeP Illes
Feb 9, 2002·British Journal of Pharmacology·Ursula UnterbergerStefan Boehm
Oct 12, 2001·The European Journal of Neuroscience·M Díaz-HernándezM T Miras-Portugal
May 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sami R FamRandy A Hall
Jan 1, 1997·Endothelium : Journal of Endothelial Cell Research·A D Duchêne, K Takeda
Nov 10, 2015·Neuropharmacology·Tobias EngelDavid C Henshall
May 28, 2011·Journal of Cellular Physiology·M ShahidullahN A Delamere
Aug 6, 2005·Neurochemistry International·Katrin Sak, Peter Illes
Apr 26, 2016·Medicinal Research Reviews·Enas M Malik, Christa E Müller
Jul 20, 2004·Journal of Cellular Biochemistry·Andrey BelousRavi S Chari
Jun 22, 2007·Clinical and Experimental Pharmacology & Physiology·Tsugumi MorikawaKazumasa Shinozuka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.